| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/12/1999 | CN1216468A Use of dipeptidyl peptidase IV inhibitors for lowering the blood glucose level mammals |
| 05/12/1999 | CN1216465A Sustained release ionic conjugate |
| 05/12/1999 | CN1216463A Compositions for the removal of dental plaque |
| 05/12/1999 | CA2251427A1 Synthetic amyloid enhancing composition |
| 05/12/1999 | CA2220805A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 05/11/1999 | US5902880 RNA polymerase III-based expression of therapeutic RNAs |
| 05/11/1999 | US5902844 Solubilizing at least one water-soluble polymer and at least one amino acid-based containing component having a high molecular weight in an aqueous solvent to form a solubilized mixture; separating the aqueous solvent, spray drying |
| 05/11/1999 | US5902817 2-sulfinyl or sulfonylpentandioic acids; inhibitors of n-acetylated alpha-linked acidic dipeptidase; glutamate abnormalities; prostates; antiepileptic and -ischemic agents; strokes; analgesics; nervous sytem injuries; |
| 05/11/1999 | US5902804 Administering a n-phosphonoglycine derivatives as an anticarcinogenic and antiviricide in human |
| 05/11/1999 | US5902799 Methods of modulating tissue growth and regeneration |
| 05/11/1999 | US5902790 Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
| 05/11/1999 | US5902789 Intranasally administering composition consisting of insulin, polysorbate-80, nonoxynol-9; reduced nasal irritation |
| 05/11/1999 | US5902788 For cutaneous melanomas |
| 05/11/1999 | US5902787 Chemically modified a-macroglobulins, methods of making, and methods of using the same in anti-cytokine therapy |
| 05/11/1999 | US5902786 Product r made by treating casein, beef peptone, bovine serum albumin and rna with sodium hydroxide and autoclaving, cooling, buffering, filtration; nonsurgical treatment |
| 05/11/1999 | US5902785 Cartilage induction by bone morphogenetic proteins |
| 05/11/1999 | US5902735 Functional DNA block and plasmid coding for hirudin, transformed yeast, method for hirudin, hirudin obtained, and its pharmaceutical use |
| 05/11/1999 | US5902608 Platelets adhered to a solid substrate that upon reconstitution adhere and spread and form a hemostatic plug to thrombogenic surfaces; do not adhere to non-thrombogenic surfaces, and release platelet-derived growth factor |
| 05/11/1999 | US5902588 Water soluble nonantigenic polymer with a secondary or tertiary amine, spacer moiety and covalent linkage to a nucleophile consisting of proteins and chemotherapeutic agents; improved bioactivity, pi and ph optimum |
| 05/11/1999 | US5902586 Meningococcal polysaccharide conjugate vaccine |
| 05/11/1999 | US5902585 Methods of inducing T cell unresponsiveness to donor tissue or organ in a recipient with GP39 antagonists |
| 05/11/1999 | US5902584 Antibodies which bind the G-CSF receptor extracelluar domain and methods of treatment |
| 05/11/1999 | US5902583 Genetic induction of receptors for targeted radiotherapy |
| 05/11/1999 | US5902582 Use of TFPI inhibitor for treatment of cancer |
| 05/11/1999 | CA2194610C Sustained-release formulation of animal growth hormone and process for preparation thereof |
| 05/11/1999 | CA2127362C Expression and purification of recombinant soluble tissue factor |
| 05/11/1999 | CA2124085C Receptor for oncostatin m and leukemia inhibitory factor |
| 05/11/1999 | CA2122724C Fusion proteins comprising mgf and il-3 |
| 05/11/1999 | CA2105861C Fish production |
| 05/11/1999 | CA2068222C Monoclonal antibodies |
| 05/11/1999 | CA2061177C Bacteriocin from lactococcus lactis subspecies lactis |
| 05/11/1999 | CA2046632C Thrombolytic from vampire bat saliva |
| 05/11/1999 | CA1340538C Recombinant coccidiosis vaccines |
| 05/07/1999 | CA2228977A1 Localized oligonucleotide therapy for preventing restenosis |
| 05/07/1999 | CA2220621A1 Transdermal delivery system |
| 05/06/1999 | WO1999022243A1 148 human secreted proteins |
| 05/06/1999 | WO1999022007A1 Cbfaie10: a human skd1 gene |
| 05/06/1999 | WO1999022006A1 CBLAFC02: A SUBUNIT OF VACUOLAR H(+)-ATPase |
| 05/06/1999 | WO1999022001A1 Method for regulating the differentiation/proliferation of hematopoietic stem cells |
| 05/06/1999 | WO1999022000A1 Inhibitor protein of the wnt signal pathway |
| 05/06/1999 | WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3 |
| 05/06/1999 | WO1999021997A1 Viral encoded semaphorin protein receptor dna and polypeptides |
| 05/06/1999 | WO1999021996A1 Methods and compositions for the diagnosis and treatment of cataracts |
| 05/06/1999 | WO1999021995A1 Treatment and prevention of neurodegenerative diseases using modulators of the interaction of app and a polypeptide defining a pi domain |
| 05/06/1999 | WO1999021994A2 Human vesicle membrane protein-like proteins |
| 05/06/1999 | WO1999021993A1 Human nip-45: interleukin-4 gene transcriptional trans-activator and its uses |
| 05/06/1999 | WO1999021992A2 Nucleic acid molecules encoding a glutamate receptor |
| 05/06/1999 | WO1999021991A1 Bmzf12: a zinc finger gene cloned from bone marrow |
| 05/06/1999 | WO1999021990A1 Cbmaad07: a voltage dependent anion channel protein |
| 05/06/1999 | WO1999021989A1 Human cofactor-a gene cbfblg07 |
| 05/06/1999 | WO1999021988A1 THE HUMAN VESICLE TRAFFICKING PROTEIN SEC22b GENE OF CBFBBA01 |
| 05/06/1999 | WO1999021987A1 Human synaptic glycoprotein sc2 homolog gene cbcbhg02 (alternative spliced short form) |
| 05/06/1999 | WO1999021985A1 Cbfbtb01: a human tif4e-like translation initiation factor |
| 05/06/1999 | WO1999021983A1 Human atrophin-1 related gene |
| 05/06/1999 | WO1999021980A1 P-40/annexin i and related proteins and their role in multidrug resistance |
| 05/06/1999 | WO1999021975A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 05/06/1999 | WO1999021968A1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES |
| 05/06/1999 | WO1999021963A1 Autodegradable microcarriers and their use |
| 05/06/1999 | WO1999021961A1 Process for making and uses of cordyceps fermentation products |
| 05/06/1999 | WO1999021890A1 New nucleotide sequences |
| 05/06/1999 | WO1999021889A1 Purification of molecules |
| 05/06/1999 | WO1999021888A1 Aggregates of human insulin derivatives |
| 05/06/1999 | WO1999021887A2 Method for the production of human blood cytokines |
| 05/06/1999 | WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR |
| 05/06/1999 | WO1999021885A1 A human abc transporter-7 (habc7) gene |
| 05/06/1999 | WO1999021884A1 Cblaeh07: a g protein gamma-5 subunit |
| 05/06/1999 | WO1999021878A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 05/06/1999 | WO1999021877A1 Histogranin peptide and their analgesic use |
| 05/06/1999 | WO1999021874A1 Oligodeoxyribonucleotides containing modified nucleoside and the like |
| 05/06/1999 | WO1999021590A1 Gene therapy for stimulation of angiogenesis |
| 05/06/1999 | WO1999021589A2 Use of vectors such as adenoviruses and/or adeno associated viruses and/or retroviruses and/or herpes simplex viruses and/or liposomes and/or plasmids as a vehicle for genetic information enabling mammal cells to produce agents for the treatment of bone pathologies |
| 05/06/1999 | WO1999021582A2 Application of tnf antagonists as medicaments for treating septic diseases |
| 05/06/1999 | WO1999021581A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
| 05/06/1999 | WO1999021578A1 Insoluble insulin compositions |
| 05/06/1999 | WO1999021577A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor |
| 05/06/1999 | WO1999021576A1 Cd8 as an inhibitor of the cellular immune system |
| 05/06/1999 | WO1999021575A1 Chemokine alpha-6 |
| 05/06/1999 | WO1999021574A2 Enhancement of morphogen activity |
| 05/06/1999 | WO1999021573A1 Fatty acid-acylated insulin analogs |
| 05/06/1999 | WO1999021572A1 Soluble mhc complexes and methods of use thereof |
| 05/06/1999 | WO1999021571A1 Melanocortin receptor ligands and methods of using same |
| 05/06/1999 | WO1999021552A1 Use of non-immunosuppressive compounds for promoting nerve regeneration |
| 05/06/1999 | WO1999021541A2 Amelioration of ischemic damage using synthetic oxygen carriers |
| 05/06/1999 | WO1999014312B1 Preparation and use of biofilm-degrading, multiple-specificity, hydrolytic enzyme mixtures |
| 05/06/1999 | WO1999013054A3 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 05/06/1999 | WO1999012963A3 Cysteine rich receptors: trail |
| 05/06/1999 | WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta |
| 05/06/1999 | WO1999010504A3 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
| 05/06/1999 | WO1999009216A3 Highly sensitive multimeric nucleic acid probes |
| 05/06/1999 | WO1999009164A9 Coding sequence haplotypes of the human brca2 gene |
| 05/06/1999 | WO1999009156A3 Protease-related protein |
| 05/06/1999 | WO1999009154A3 Novel hiv-specific synthetic oligonucleotides and methods of their use |
| 05/06/1999 | WO1999009045A9 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 05/06/1999 | WO1999008729A9 Loading and release of water-insoluble drugs |
| 05/06/1999 | WO1999008701A8 Complexes of apolipoprotein e and ciliary neurotrophic factor (cntf) and methods of use |
| 05/06/1999 | WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides |
| 05/06/1999 | WO1998058958A9 Human jagged polypeptide, encoding nucleic acids and methods of use |
| 05/06/1999 | WO1998055455A9 Modification of platelet action by fibrinogen-coated particles |
| 05/06/1999 | WO1998054301B1 Transplants for myocardial scars and method and cellular preparations therefor |
| 05/06/1999 | EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB) |